Purpose: To determine whether multivariate machine learning models of algorithmically assessed magnetic resonance imaging (MRI) features from breast cancer patients are associated with Oncotype DX (ODX) test recurrence scores.

Methods: A set of 261 female patients with invasive breast cancer, pre-operative dynamic contrast enhanced magnetic resonance (DCE-MR) images and available ODX score at our institution was identified. A computer algorithm extracted a comprehensive set of 529 features from the DCE-MR images of these patients. The set of patients was divided into a training set and a test set. Using the training set we developed two machine learning-based models to discriminate (1) high ODX scores from intermediate and low ODX scores, and (2) high and intermediate ODX scores from low ODX scores. The performance of these models was evaluated on the independent test set.

Results: High against low and intermediate ODX scores were predicted by the multivariate model with AUC 0.77 (95% CI 0.56-0.98, p < 0.003). Low against intermediate and high ODX score was predicted with AUC 0.51 (95% CI 0.41-0.61, p = 0.75).

Conclusion: A moderate association between imaging and ODX score was identified. The evaluated models currently do not warrant replacement of ODX with imaging alone.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920720PMC
http://dx.doi.org/10.1007/s00432-018-2595-7DOI Listing

Publication Analysis

Top Keywords

odx scores
20
multivariate machine
8
machine learning
8
learning models
8
magnetic resonance
8
breast cancer
8
dce-mr images
8
training set
8
low odx
8
intermediate odx
8

Similar Publications

Purpose: Multigene assays guide treatment decisions in early-stage hormone receptor-positive breast cancer. OncoFREE, a next-generation sequencing assay using 179 genes, was developed for this purpose. This study aimed to evaluate the concordance between the Oncotype DX (ODX) Recurrence Score (RS) and the OncoFREE Decision Index (DI) and to compare their performance.

View Article and Find Full Text PDF

Background: The Oncotype DX Genomic Prostate Score (ODX-GPS) is a gene expression assay that predicts disease aggressiveness. The objective of this study was to identify sociodemographic and regional factors associated with ODX-GPS uptake.

Methods: Data from Surveillance Epidemiology and End Results registries on men with localized prostate cancer with a Gleason score of 3 + 3 or 3 + 4, PSA ≤20 ng/mL, and stage T1c to T2c disease from 2013 through 2017 were linked with ODX-GPS data.

View Article and Find Full Text PDF
Article Synopsis
  • Chemotherapy is essential for treating certain breast cancers, and the balance between its benefits and side effects can be assessed using the Oncotype DX (ODX) test, although it's costly.
  • Researchers aimed to create a nomogram to predict the recurrence score (RS) using clinicopathological variables, which could help identify patients who might not need the ODX test.
  • The study found that factors like progesterone receptor levels and histological grade effectively predicted RS, with their nomogram showing high accuracy and the potential for cost savings in clinical evaluations.
View Article and Find Full Text PDF

Introduction: Breast Cancer Index (BCI) is a genomic assay that evaluates the benefit of extending endocrine therapy (ET) from 5 to 10 years and predicts recurrence risk (RR). We evaluated the association between BCI and Oncotype DX (ODX).

Patients: Women with hormone receptor (HR)-positive early-stage breast cancer (EBC) who had BCI and ODX performed were included.

View Article and Find Full Text PDF
Article Synopsis
  • * Data from 114 Japanese women revealed that low tumor grade, high progesterone receptor (PgR) expression, and low Ki67 labeling index (LI) were significantly associated with lower recurrence scores.
  • * The findings suggest that PgR expression and Ki67 LI are independent predictors of recurrence score, and MUC1 staining patterns could also be valuable in identifying patients who may not benefit from the test.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!